المؤلفون: Carmona, SJ, Teichmann, SA, Ferreira, L, Macaulay, IC, Stubbington, MJT, Cvejic, A, Gfeller, D

مصطلحات موضوعية: Receptors, IgG, Zebrafish Proteins, 3. Good health, Evolution, Molecular, Killer Cells, Natural, Mice, Animals, Humans, 14. Life underwater, Single-Cell Analysis, Transcriptome, Cells, Cultured, Conserved Sequence, Zebrafish

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::26bb23ee184f321cedfc84d37ebee751

المؤلفون: Pereira-Gonzalez I; Department of Ophthalmology, Juan Ramon Jimenez University Hospital, Huelva, Andalusia, Spain., Sanchez JB; Department of Ophthalmology, University of Cadiz, University Hospital of Jerez, Jerez de la Frontera, Cadiz, Andalusia, Spain., Carmona SJ; Department of Ophthalmology, University of Cadiz, Puerta del Mar University Hospital, Cadiz, Andalusia, Spain., Cordoba Doña JA; Department of Preventive Medicine and Public Health, University of Cadiz, University Hospital of Jerez, Jerez de la Frontera, Cadiz, Andalusia, Spain.

المصدر: European journal of ophthalmology [Eur J Ophthalmol] 2024 Aug 07, pp. 11206721241272239. Date of Electronic Publication: 2024 Aug 07.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: SAGE Publishing Country of Publication: United States NLM ID: 9110772 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1724-6016 (Electronic) Linking ISSN: 11206721 NLM ISO Abbreviation: Eur J Ophthalmol Subsets: MEDLINE

المؤلفون: Andreatta M; Department of Oncology, Lausanne Branch, Ludwig Institute for Cancer Research, CHUV and University of Lausanne, 1011, Lausanne, Switzerland.; AGORA Cancer Research Center, 1005, Lausanne, Switzerland.; Swiss Institute of Bioinformatics, 1015, Lausanne, Switzerland., Hérault L; Department of Oncology, Lausanne Branch, Ludwig Institute for Cancer Research, CHUV and University of Lausanne, 1011, Lausanne, Switzerland.; AGORA Cancer Research Center, 1005, Lausanne, Switzerland.; Swiss Institute of Bioinformatics, 1015, Lausanne, Switzerland., Gueguen P; Department of Oncology, Lausanne Branch, Ludwig Institute for Cancer Research, CHUV and University of Lausanne, 1011, Lausanne, Switzerland.; AGORA Cancer Research Center, 1005, Lausanne, Switzerland.; Swiss Institute of Bioinformatics, 1015, Lausanne, Switzerland., Gfeller D; Department of Oncology, Lausanne Branch, Ludwig Institute for Cancer Research, CHUV and University of Lausanne, 1011, Lausanne, Switzerland.; AGORA Cancer Research Center, 1005, Lausanne, Switzerland.; Swiss Institute of Bioinformatics, 1015, Lausanne, Switzerland., Berenstein AJ; Laboratorio de Biología Molecular, División Patología, Instituto Multidisciplinario de Investigaciones en Patologías Pediátricas (IMIPP), CONICET-GCBA, Buenos Aires, C1425EFD, Argentina., Carmona SJ; Department of Oncology, Lausanne Branch, Ludwig Institute for Cancer Research, CHUV and University of Lausanne, 1011, Lausanne, Switzerland. santiago.carmona@unil.ch.; AGORA Cancer Research Center, 1005, Lausanne, Switzerland. santiago.carmona@unil.ch.; Swiss Institute of Bioinformatics, 1015, Lausanne, Switzerland. santiago.carmona@unil.ch.

المصدر: Nature communications [Nat Commun] 2024 Jan 29; Vol. 15 (1), pp. 872. Date of Electronic Publication: 2024 Jan 29.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

مواضيع طبية MeSH: Single-Cell Analysis*/methods , Gene Expression Profiling*/methods, Humans ; Sequence Analysis, RNA/methods

المؤلفون: Tillé L; Department of Oncology, UNIL CHUV, University of Lausanne, Lausanne, Switzerland.; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland., Cropp D; Department of Oncology, UNIL CHUV, University of Lausanne, Lausanne, Switzerland.; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland., Charmoy M; Department of Oncology, UNIL CHUV, University of Lausanne, Lausanne, Switzerland., Reichenbach P; Department of Oncology, UNIL CHUV, University of Lausanne, Lausanne, Switzerland.; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland., Andreatta M; Department of Oncology, UNIL CHUV, University of Lausanne, Lausanne, Switzerland.; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland., Wyss T; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland., Bodley G; Department of Oncology, UNIL CHUV, University of Lausanne, Lausanne, Switzerland., Crespo I; Department of Oncology, UNIL CHUV, University of Lausanne, Lausanne, Switzerland.; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland., Nassiri S; Department of Oncology, UNIL CHUV, University of Lausanne, Lausanne, Switzerland.; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland., Lourenco J; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland., Leblond MM; Department of Oncology, UNIL CHUV, University of Lausanne, Lausanne, Switzerland.; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland., Lopez-Rodriguez C; Immunology Unit, Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain., Speiser DE; Department of Oncology, UNIL CHUV, University of Lausanne, Lausanne, Switzerland., Coukos G; Department of Oncology, UNIL CHUV, University of Lausanne, Lausanne, Switzerland.; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland., Irving M; Department of Oncology, UNIL CHUV, University of Lausanne, Lausanne, Switzerland.; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland., Carmona SJ; Department of Oncology, UNIL CHUV, University of Lausanne, Lausanne, Switzerland.; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland., Held W; Department of Oncology, UNIL CHUV, University of Lausanne, Lausanne, Switzerland., Verdeil G; Department of Oncology, UNIL CHUV, University of Lausanne, Lausanne, Switzerland. gregory.verdeil@unil.ch.; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland. gregory.verdeil@unil.ch.

المصدر: Nature immunology [Nat Immunol] 2023 Oct; Vol. 24 (10), pp. 1645-1653. Date of Electronic Publication: 2023 Sep 14.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature America Inc Country of Publication: United States NLM ID: 100941354 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1529-2916 (Electronic) Linking ISSN: 15292908 NLM ISO Abbreviation: Nat Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Lymphocytic Choriomeningitis* , Neoplasms*/metabolism, Humans ; Transcription Factors/metabolism ; CD8-Positive T-Lymphocytes ; T-Cell Exhaustion ; Persistent Infection ; Tumor Microenvironment ; Programmed Cell Death 1 Receptor/genetics ; Programmed Cell Death 1 Receptor/metabolism ; Lymphocytic choriomeningitis virus

المؤلفون: Andreatta M; Ludwig Institute for Cancer Research, Lausanne Branch, and Department of Oncology, CHUV and University of Lausanne, Epalinges, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland.; Swiss Institute of Bioinformatics, Lausanne, Switzerland., Gueguen P; Ludwig Institute for Cancer Research, Lausanne Branch, and Department of Oncology, CHUV and University of Lausanne, Epalinges, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland.; Swiss Institute of Bioinformatics, Lausanne, Switzerland., Borcherding N; Department of Pathology & Immunology, Washington University in St. Louis, St. Louis, MO, USA., Carmona SJ; Ludwig Institute for Cancer Research, Lausanne Branch, and Department of Oncology, CHUV and University of Lausanne, Epalinges, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland.; Swiss Institute of Bioinformatics, Lausanne, Switzerland.

المصدر: Bio-protocol [Bio Protoc] 2023 Aug 20; Vol. 13 (16), pp. e4735. Date of Electronic Publication: 2023 Aug 20 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Bio-protocol LLC Country of Publication: United States NLM ID: 101635102 Publication Model: eCollection Cited Medium: Internet ISSN: 2331-8325 (Electronic) Linking ISSN: 23318325 NLM ISO Abbreviation: Bio Protoc Subsets: PubMed not MEDLINE

المؤلفون: Chang YW; Cancer and Immunology Research Center, National Yang Ming Chiao Tung University, Taipei 11221, Taiwan., Hsiao HW; Elixiron Immunotherapeutics (Hong Kong) Ltd., Hong Kong., Chen JP; Cancer and Immunology Research Center, National Yang Ming Chiao Tung University, Taipei 11221, Taiwan., Tzeng SF; Graduate Institute of Life Sciences, National Defense Medical Center, Taipei 11221, Taiwan., Tsai CH; Graduate Institute of Life Sciences, National Defense Medical Center, Taipei 11221, Taiwan., Wu CY; Department of Biomedical Imaging and Radiological Sciences, National Yang Ming Chiao Tung University, Taipei 11221, Taiwan., Hsieh HH; Department of Biomedical Imaging and Radiological Sciences, National Yang Ming Chiao Tung University, Taipei 11221, Taiwan., Carmona SJ; Department of Oncology, University of Lausanne, Lausanne, Switzerland; Ludwig Institute for Cancer Research at University of Lausanne, Lausanne, Switzerland., Andreatta M; Department of Oncology, University of Lausanne, Lausanne, Switzerland; Ludwig Institute for Cancer Research at University of Lausanne, Lausanne, Switzerland., Di Conza G; Department of Oncology, University of Lausanne, Lausanne, Switzerland; Ludwig Institute for Cancer Research at University of Lausanne, Lausanne, Switzerland., Su MT; Department of Biotechnology and Laboratory Science in Medicine, National Yang Ming Chiao Tung University, Taipei 11221, Taiwan., Koni PA; Elixiron Immunotherapeutics (Hong Kong) Ltd., Hong Kong., Ho PC; Department of Oncology, University of Lausanne, Lausanne, Switzerland; Ludwig Institute for Cancer Research at University of Lausanne, Lausanne, Switzerland., Chen HK; Elixiron Immunotherapeutics (Hong Kong) Ltd., Hong Kong. Electronic address: hkchen@elixiron.com., Yang MH; Cancer and Immunology Research Center, National Yang Ming Chiao Tung University, Taipei 11221, Taiwan; Department of Biotechnology and Laboratory Science in Medicine, National Yang Ming Chiao Tung University, Taipei 11221, Taiwan; Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei 11221, Taiwan; Department of Oncology, Taipei Veterans General Hospital, Taipei 11217, Taiwan; Department of Teaching and Research, Taipei City Hospital, Taipei, Taiwan. Electronic address: mhyang2@nycu.edu.tw.

المصدر: Cell reports. Medicine [Cell Rep Med] 2023 Aug 15; Vol. 4 (8), pp. 101154.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: Print Cited Medium: Internet ISSN: 2666-3791 (Electronic) Linking ISSN: 26663791 NLM ISO Abbreviation: Cell Rep Med Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms*/pathology , Antineoplastic Agents*/pharmacology, Humans ; CD8-Positive T-Lymphocytes ; Interleukin-10/metabolism ; Receptor Protein-Tyrosine Kinases/metabolism ; Receptors, Colony-Stimulating Factor/metabolism ; Tumor Microenvironment

المؤلفون: Corria-Osorio J; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne; and Department of Oncology, Lausanne University Hospital, Epalinges, Switzerland. angeldejesus.corriaosorio@unil.ch.; AGORA Cancer Research Center, Lausanne, Switzerland. angeldejesus.corriaosorio@unil.ch., Carmona SJ; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne; and Department of Oncology, Lausanne University Hospital, Epalinges, Switzerland.; AGORA Cancer Research Center, Lausanne, Switzerland., Stefanidis E; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne; and Department of Oncology, Lausanne University Hospital, Epalinges, Switzerland., Andreatta M; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne; and Department of Oncology, Lausanne University Hospital, Epalinges, Switzerland.; AGORA Cancer Research Center, Lausanne, Switzerland., Ortiz-Miranda Y; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne; and Department of Oncology, Lausanne University Hospital, Epalinges, Switzerland.; AGORA Cancer Research Center, Lausanne, Switzerland., Muller T; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne; and Department of Oncology, Lausanne University Hospital, Epalinges, Switzerland.; AGORA Cancer Research Center, Lausanne, Switzerland., Rota IA; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne; and Department of Oncology, Lausanne University Hospital, Epalinges, Switzerland.; AGORA Cancer Research Center, Lausanne, Switzerland., Crespo I; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne; and Department of Oncology, Lausanne University Hospital, Epalinges, Switzerland.; AGORA Cancer Research Center, Lausanne, Switzerland., Seijo B; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne; and Department of Oncology, Lausanne University Hospital, Epalinges, Switzerland.; AGORA Cancer Research Center, Lausanne, Switzerland., Castro W; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne; and Department of Oncology, Lausanne University Hospital, Epalinges, Switzerland.; AGORA Cancer Research Center, Lausanne, Switzerland., Jimenez-Luna C; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne; and Department of Oncology, Lausanne University Hospital, Epalinges, Switzerland., Scarpellino L; Department of Immunobiology, University of Lausanne, Epalinges, Switzerland., Ronet C; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne; and Department of Oncology, Lausanne University Hospital, Epalinges, Switzerland.; AGORA Cancer Research Center, Lausanne, Switzerland., Spill A; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne; and Department of Oncology, Lausanne University Hospital, Epalinges, Switzerland.; AGORA Cancer Research Center, Lausanne, Switzerland., Lanitis E; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne; and Department of Oncology, Lausanne University Hospital, Epalinges, Switzerland., Romero P; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne; and Department of Oncology, Lausanne University Hospital, Epalinges, Switzerland.; AGORA Cancer Research Center, Lausanne, Switzerland., Luther SA; Department of Immunobiology, University of Lausanne, Epalinges, Switzerland., Irving M; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne; and Department of Oncology, Lausanne University Hospital, Epalinges, Switzerland., Coukos G; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne; and Department of Oncology, Lausanne University Hospital, Epalinges, Switzerland. george.coukos@chuv.ch.; AGORA Cancer Research Center, Lausanne, Switzerland. george.coukos@chuv.ch.

المصدر: Nature immunology [Nat Immunol] 2023 May; Vol. 24 (5), pp. 869-883. Date of Electronic Publication: 2023 Apr 20.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature America Inc Country of Publication: United States NLM ID: 100941354 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1529-2916 (Electronic) Linking ISSN: 15292908 NLM ISO Abbreviation: Nat Immunol Subsets: MEDLINE

مواضيع طبية MeSH: CD8-Positive T-Lymphocytes*/immunology , Interleukin-2*/pharmacology , Neoplasms, Experimental*/therapy , Immunotherapy, Adoptive*, T-Cell Exhaustion ; Lymphocytes, Tumor-Infiltrating/immunology ; Interleukin-33 ; Protein Engineering ; Female ; Animals ; Mice ; Mice, Inbred C57BL ; Cell Line, Tumor ; Programmed Cell Death 1 Receptor/metabolism

المؤلفون: Bilous M; Department of Oncology, Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.; Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland., Tran L; Department of Oncology, Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.; Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland., Cianciaruso C; Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland., Gabriel A; Department of Oncology, Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.; Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland., Michel H; Department of Oncology, Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland., Carmona SJ; Department of Oncology, Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.; Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland., Pittet MJ; Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland.; Department of Oncology, Geneva University Hospitals, Geneva, Switzerland.; Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Gfeller D; Department of Oncology, Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland. David.Gfeller@unil.ch.; Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland. David.Gfeller@unil.ch.

المصدر: BMC bioinformatics [BMC Bioinformatics] 2022 Aug 13; Vol. 23 (1), pp. 336. Date of Electronic Publication: 2022 Aug 13.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100965194 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2105 (Electronic) Linking ISSN: 14712105 NLM ISO Abbreviation: BMC Bioinformatics Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19* , Transcriptome*, Cluster Analysis ; Humans ; Sequence Analysis, RNA/methods ; Single-Cell Analysis/methods

المؤلفون: Andreatta M; Department of Oncology, UNIL CHUV and Ludwig Institute for Cancer Research Lausanne, University of Lausanne, Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland.; Swiss Institute of Bioinformatics, Lausanne, Switzerland., Tjitropranoto A; David H. Smith Center for Vaccine Biology and Immunology, Department of Microbiology and Immunology, University of Rochester, Rochester, United States., Sherman Z; David H. Smith Center for Vaccine Biology and Immunology, Department of Microbiology and Immunology, University of Rochester, Rochester, United States., Kelly MC; Single Cell Analysis Facility, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc, Frederick, United States., Ciucci T; David H. Smith Center for Vaccine Biology and Immunology, Department of Microbiology and Immunology, University of Rochester, Rochester, United States.; Laboratory of Immune Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, United States., Carmona SJ; Department of Oncology, UNIL CHUV and Ludwig Institute for Cancer Research Lausanne, University of Lausanne, Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland.; Swiss Institute of Bioinformatics, Lausanne, Switzerland.

المصدر: ELife [Elife] 2022 Jul 13; Vol. 11. Date of Electronic Publication: 2022 Jul 13.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE

مواضيع طبية MeSH: T-Lymphocytes* , Virus Diseases*, Animals ; CD4-Positive T-Lymphocytes ; Mice ; Receptors, Antigen, T-Cell/genetics

المؤلفون: Biermann J; Department of Medicine, Division of Hematology/Oncology, and Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY 10032, USA; Program for Mathematical Genomics, Columbia University, New York, NY 10032, USA., Melms JC; Department of Medicine, Division of Hematology/Oncology, and Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY 10032, USA; Columbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, NY 10032, USA., Amin AD; Department of Medicine, Division of Hematology/Oncology, and Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY 10032, USA; Columbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, NY 10032, USA., Wang Y; Department of Medicine, Division of Hematology/Oncology, and Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY 10032, USA; Program for Mathematical Genomics, Columbia University, New York, NY 10032, USA., Caprio LA; Department of Medicine, Division of Hematology/Oncology, and Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY 10032, USA; Columbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, NY 10032, USA., Karz A; Department of Pathology, NYU Grossman School of Medicine, New York, NY 10016, USA., Tagore S; Department of Systems Biology, Columbia University Irving Medical Center, New York, NY 10032, USA., Barrera I; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Ibarra-Arellano MA; Heidelberg University, Faculty of Medicine, and Heidelberg University Hospital, Institute for Computational Biomedicine, Bioquant, 69120 Heidelberg, Germany., Andreatta M; Department of Oncology UNIL CHUV, Lausanne Branch, Ludwig Institute for Cancer Research Lausanne, CHUV and University of Lausanne, Lausanne, 1066 Épalinges, Switzerland; Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland., Fullerton BT; Department of Medicine, Division of Hematology/Oncology, and Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY 10032, USA., Gretarsson KH; Department of Genetics and Development, Columbia University Medical Center, New York, NY 10032, USA., Sahu V; Department of Genetics and Development, Columbia University Medical Center, New York, NY 10032, USA., Mangipudy VS; Department of Genetics and Development, Columbia University Medical Center, New York, NY 10032, USA., Nguyen TTT; Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY 10032, USA., Nair A; Department of Medicine, Division of Hematology/Oncology, and Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY 10032, USA., Rogava M; Department of Medicine, Division of Hematology/Oncology, and Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY 10032, USA; Columbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, NY 10032, USA., Ho P; Department of Medicine, Division of Hematology/Oncology, and Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY 10032, USA; Columbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, NY 10032, USA., Koch PD; Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032, USA., Banu M; Department of Neurological Surgery, New York Presbyterian/Columbia University Irving Medical Center, New York, NY 10032, USA., Humala N; Department of Neurological Surgery, New York Presbyterian/Columbia University Irving Medical Center, New York, NY 10032, USA., Mahajan A; Department of Neurological Surgery, New York Presbyterian/Columbia University Irving Medical Center, New York, NY 10032, USA., Walsh ZH; Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032, USA., Shah SB; Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032, USA., Vaccaro DH; Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032, USA., Caldwell B; Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032, USA., Mu M; Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032, USA., Wünnemann F; Heidelberg University, Faculty of Medicine, and Heidelberg University Hospital, Institute for Computational Biomedicine, Bioquant, 69120 Heidelberg, Germany., Chazotte M; Heidelberg University, Faculty of Medicine, and Heidelberg University Hospital, Institute for Computational Biomedicine, Bioquant, 69120 Heidelberg, Germany., Berhe S; Department of Medicine, Division of Hematology/Oncology, and Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY 10032, USA., Luoma AM; Department of Cancer Immunology and Virology, Dana-Farber Cancer Center, Boston, MA 02215, USA., Driver J; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA., Ingham M; Department of Medicine, Division of Hematology/Oncology, and Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY 10032, USA., Khan SA; Department of Medicine, Division of Hematology/Oncology, and Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY 10032, USA., Rapisuwon S; Division of Hematology/Oncology, Medstar Washington Cancer Institute, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20007, USA., Slingluff CL Jr; Department of Surgery, University of Virginia, Charlottesville, VA, USA., Eigentler T; Department of Dermatology, Eberhard Karls University Tübingen, 72076 Tübingen, Germany; Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Dermatology, Venereology and Allergology, 10117, Berlin, Germany., Röcken M; Department of Dermatology, Eberhard Karls University Tübingen, 72076 Tübingen, Germany., Carvajal R; Department of Medicine, Division of Hematology/Oncology, and Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY 10032, USA., Atkins MB; Georgetown-Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20007, USA., Davies MA; Department of Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA., Agustinus A; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Pharmacology, Weill Cornell Graduate School, New York, NY 10065, USA., Bakhoum SF; Department of Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Azizi E; Department of Biomedical Engineering, Columbia University, New York, NY 10027, USA; Irving Institute for Cancer Dynamics, Columbia University, New York, NY 10027, USA., Siegelin M; Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY 10032, USA., Lu C; Department of Genetics and Development, Columbia University Medical Center, New York, NY 10032, USA., Carmona SJ; Department of Oncology UNIL CHUV, Lausanne Branch, Ludwig Institute for Cancer Research Lausanne, CHUV and University of Lausanne, Lausanne, 1066 Épalinges, Switzerland; Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland., Hibshoosh H; Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY 10032, USA., Ribas A; Department of Medicine, Jonsson Comprehensive Cancer Center, University of California, Los Angeles (UCLA), Los Angeles, CA 90024, USA., Canoll P; Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY 10032, USA., Bruce JN; Department of Neurological Surgery, New York Presbyterian/Columbia University Irving Medical Center, New York, NY 10032, USA., Bi WL; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Agrawal P; Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York, NY 10461, USA., Schapiro D; Heidelberg University, Faculty of Medicine, and Heidelberg University Hospital, Institute for Computational Biomedicine, Bioquant, 69120 Heidelberg, Germany; Institute of Pathology, Heidelberg University Hospital, 69120 Heidelberg, Germany., Hernando E; Department of Pathology, NYU Grossman School of Medicine, New York, NY 10016, USA., Macosko EZ; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Department of Psychiatry, Massachusetts General Hospital, Boston, MA 02114, USA., Chen F; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA., Schwartz GK; Department of Medicine, Division of Hematology/Oncology, and Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY 10032, USA., Izar B; Department of Medicine, Division of Hematology/Oncology, and Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY 10032, USA; Program for Mathematical Genomics, Columbia University, New York, NY 10032, USA; Columbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, NY 10032, USA. Electronic address: bi2175@cumc.columbia.edu.

المصدر: Cell [Cell] 2022 Jul 07; Vol. 185 (14), pp. 2591-2608.e30.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 0413066 Publication Model: Print Cited Medium: Internet ISSN: 1097-4172 (Electronic) Linking ISSN: 00928674 NLM ISO Abbreviation: Cell Subsets: MEDLINE

مواضيع طبية MeSH: Brain Neoplasms*/drug therapy , Brain Neoplasms*/secondary , Melanoma*, CD8-Positive T-Lymphocytes/pathology ; Ecosystem ; Humans ; RNA-Seq